Microbiome Testing in NZ: Worth It, or Marketing Theatre?

Are microbiome tests worth it in New Zealand?

For routine diet personalisation, usually not. Evidence that consumer profiles improve clinical decisions remains insufficient. That is different from saying the microbiome does not matter. 1

Colour-coded charts and tailored food lists can look persuasive. Before buying, ask a simpler question: what would I do differently because of this result?

This is a guide to evaluating the test, not a ranking of NZ suppliers. A useful assessment needs to separate measurement quality from the usefulness of the advice.

What the panels actually report

Consumer reports can include:

• Relative abundance: the proportion assigned to bacterial groups, rather than an absolute bacterial count. 2
• Diversity indices: calculations summarising the variety and distribution of detected microbes. 2
• Predicted functions: inferred capabilities, not direct measurements of short-chain fatty acid production. 1
• Traffic-light scores and food lists: interpretations layered onto the results. 1

Methods include 16S rRNA gene sequencing, which targets a marker gene, and shotgun metagenomics, which analyses DNA more broadly. Neither method alone establishes clinical usefulness. 2

A relative percentage can rise because other bacteria declined. It does not necessarily mean that organism multiplied. Read percentages as proportions, not a census of your gut. 2

Strict healthy abundance ranges are not established for many organisms. A population association does not prove that a bacterium causes your symptoms or needs correcting. 1

Clinical gut tests answer different questions

Your GP can assess symptoms and select investigations. You do not need to arrange a consumer profile before that appointment. 3

Faecal calprotectin assesses intestinal inflammation and can help distinguish inflammatory bowel disease from IBS in an appropriate clinical context. It is not a diagnosis by itself. 3

Targeted pathogen tests, including PCR, look for particular infectious organisms. They are not comprehensive microbiome profiles. 1

Coeliac screening usually starts with blood testing. Do not start a gluten-free diet before discussing testing, because excluding gluten can make results unreliable. 4

SIBO breath testing needs more caution. It may be considered in selected circumstances, but results can be affected by intestinal transit, especially with lactulose. 5

Professional recommendations differ. Breath testing should not be presented as a routine, definitive answer to unexplained bloating or IBS-type symptoms. 5

Where the food evidence is useful

The American Gut study found greater microbial diversity among people reporting more than 30 plant types weekly than among those reporting 10 or fewer. This was an association, not a treatment trial. 6

It does not establish a required plant count, typical NZ intake or a deadline for better digestion. Variety is a useful idea; 30 is not a pass mark. 6

The Stanford dietary study analysed 18 generally healthy adults per group. Its 10-week intervention included four weeks of increasing intake and six weeks of maintenance, within a 17-week protocol. 7

The fermented-food group reached about six servings daily. Microbial diversity increased and several inflammatory markers fell. The primary cytokine-response outcome did not significantly change. 7

There was no usual-diet control group. These findings do not prove that one daily yoghurt treats symptoms, prevents disease or reproduces the study's effects. 7

The high-fibre group increased microbial carbohydrate-processing capacity without increasing overall diversity. A diversity score is therefore not the only way diet can affect the microbiome. 7

Microbial fermentation produces short-chain fatty acids, including butyrate, which contribute to the intestinal environment. That biology does not make a predicted report score a direct measure of gut health. 8

Where interpretation gets speculative

A 2026 study sent standardised stool material to seven consumer testing services. It found substantial differences within and between providers, sometimes comparable with differences between donors. 2

That was not a test of every NZ service. It does show why a change between reports cannot automatically be labelled improvement or deterioration. 2

Probiotics can temporarily colonise parts of the gut, with persistence varying by strain and person. Permanent residence is not required for every potential effect. 8

Benefits depend on the product, condition and outcome studied. Evidence for one strain cannot simply be transferred to another, and selecting probiotics for IBS remains uncertain. 8

The fermented-food trial was not a comparison against probiotic supplements. It cannot establish that fermented foods are the more reliable treatment. 7

What to work on without a panel

Build variety without forcing it. Try rotating kūmara, oats, legumes, berries, leafy greens, nuts and seeds. Choose affordable foods you enjoy rather than designing meals around a bacterial score.

Match fibre to tolerance. Soluble fibre can help constipation, while some people with IBS feel worse with additional bran. More fibre is not automatically better for every symptom. 3

For a practical progression, see How to Increase Fibre Without Making Bloating Worse.

Treat fermented foods as an option. Try plain yoghurt, kefir, sauerkraut or kimchi if you enjoy and tolerate them. You do not need to copy the study's high intake.

Keep meals regular and unhurried. Chew thoroughly and review whether alcohol or particular meals coincide with symptoms. Stress management can also form part of IBS care. 3

Keep sleep, adequate overall food intake and protein in your food diary too. Use the diary to identify questions, not to diagnose a deficiency or claim you have measured your microbiome.

When a microbiome test might help

Research is a legitimate setting for profiling. A study can specify its methods, question and analysis in advance. That does not make the same panel an established routine treatment tool. 1

Persistent symptoms after initial care do not establish an indication for consumer profiling. Nor is routine post-antibiotic recovery tracking a validated clinical use. 1

Before paying, ask:

• What precise decision will this result change?
• Has that approach improved patient outcomes in a suitable trial?
• Can the service demonstrate repeatability?
• Are proposed functions measured or predicted?
• What is the total cost, including interpretation and follow-up?
• Does the provider sell the recommended supplements?
• How will my sample and data be stored, shared or deleted?

Curiosity is a different purchase from healthcare. Decide which you are buying.

What to do this week, and when to seek help

List your usual plant foods and choose a few realistic additions. Try one change at a time, rather than adding several supplements and foods together.

Record meals, bowel habits, pain and bloating. A food-and-symptom diary can support assessment, although it does not prove causation. 3

Book a GP appointment for persistent, recurring or disruptive symptoms. Do not wait to complete a month of dietary changes. Mention unexplained weight loss, bleeding or symptoms waking you at night. 3

Seek urgent medical help for severe or worsening abdominal pain, or vomiting that prevents you keeping fluids down. Blood in your stool also needs prompt assessment. 9

The priority is a useful next decision, not a more impressive report.